Insulet reported a higher-than-expected profit in the fourth quarter on Thursday, driven by strong demand for its wearable insulin pumps. The company produces and sells Omnipod, an automated insulin ...
In an “urgent medical device correction,” the company urges clinicians to remind patients to monitor their glucose levels during takeoffs and landings.
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...
Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...
News Medical on MSN10d
New UVA clinical trial explores AI-powered insulin delivery for better diabetes careand Tandem insulin pump — to enable insulin delivery without requiring user input. The goal? To see if this new feature can ...
Baird last night initiated coverage of Beta Bionics (BBNX) with a Neutral rating and $20 price target The firm believes Beta’s iLet Bionic ...
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
The global Insulin Delivery Devices Market was valued at USD 30.9 billion in 2022 and is expected to grow significantly, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback